MSD
The Quantitative Pharmacology and Pharmacometrics (QP2) department seeks a visionary Pharmacometrics AI Lead to drive the integration of artificial intelligence, machine learning, and digital technologies into quantitative pharmacology workflows. This Director-level role will shape next-generation Model-Informed Drug Discovery and Development (MIDD) approaches, accelerate decision-making, and lead a talented team of pharmacometricians using cutting-edge AI, advanced analytics, and automation tools.
At MSD, we're following the science to tackle some of the world's greatest health threats. Get a glimpse of how we work to improve lives.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for MSD.
17% above the average for this role
MSD ends takeover talks with Revolution Medicines
1 month ago
Pharmacometrics AI Lead
Merck & Co., Inc.
Senior Director, Advanced Pharmacometrics
Merck & Co., Inc.
Director of Pharmacometrics- Clinical Pharmacology
Kyowa Kirin
Director, Infectious Diseases and Vaccines, Quantitative Pharmacology and Pharmacometrics
Merck & Co., Inc.
Pharmacometrics Team Lead (Belgium)
City of Winnipeg
Sr. Director, Clinical Pharmacology & Pharmacometrics
GondolaBio Service Co, Inc.